Plus Therapeutics Inc (PSTV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -18,744 | -37,368 | -26,177 | -32,279 | -32,451 |
| Depreciation Amortization | 2,072 | 1,999 | 2,523 | 1,863 | 1,566 |
| Accounts receivable | 328 | 2,057 | -1,209 | -1,810 | -670 |
| Other Working Capital | 1,303 | 364 | -7,112 | -5,781 | -4,086 |
| Other Operating Activity | -5,427 | 2,618 | -2,588 | 5,814 | 318 |
| Operating Cash Flow | $-20,468 | $-30,330 | $-34,563 | $-32,193 | $-35,323 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -600 | -688 | 4,481 | -1,204 | -560 |
| Net Acquisitions | N/A | N/A | 5 | N/A | N/A |
| Purchase Sale Intangibles | -13 | -255 | 0 | N/A | N/A |
| Other Investing Activity | -13 | -655 | -800 | 0 | 0 |
| Investing Cash Flow | $-613 | $-1,343 | $3,686 | $-1,204 | $-560 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 17,700 | 0 | 27,000 | 0 | 9,444 |
| Debt Repayment | -25,032 | -1,962 | -22,304 | -2,692 | -4,529 |
| Common Stock Issued | 34,051 | 23,152 | 18,225 | 26,366 | 16,135 |
| Dividend Paid | -75 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -5,847 | 9,684 | -2,149 | -1,482 | -913 |
| Financing Cash Flow | $20,797 | $30,874 | $20,772 | $22,192 | $20,137 |
| Exchange Rate Effect | 0 | -85 | -106 | 0 | 0 |
| Beginning Cash Position | 14,622 | 15,506 | 25,717 | 36,922 | 52,668 |
| End Cash Position | 14,338 | 14,622 | 15,506 | 25,717 | 36,922 |
| Net Cash Flow | $-284 | $-884 | $-10,211 | $-11,205 | $-15,746 |
| Free Cash Flow | |||||
| Operating Cash Flow | -20,468 | -30,330 | -34,563 | -32,193 | -35,323 |
| Capital Expenditure | -611 | -764 | -519 | -1,204 | -560 |
| Free Cash Flow | -21,079 | -31,094 | -35,082 | -33,397 | -35,883 |